Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 406 AL 420

Air pollution, glymphatic impairment, and Alzheimer's disease

Hussain R, Graham U, Elder A, Nedergaard M.

Trends Neurosci. 2023 Nov;46(11):901-911. doi: 10.1016/j.tins.2023.08.010. Epub 2023 Sep 28.

Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications

Bredesen DE, Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Kurakin A, Jarrett M.

J Alzheimers Dis. 2023;96(2):429-437. doi: 10.3233/JAD-230467.

Etiology of Alzheimer's Disease

Zhang C.

Discov Med. 2023 Oct;35(178):757-776. doi: 10.24976/Discov.Med.202335178.71.

Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Rabinovici GD, Carrillo MC, Apgar C, Gareen IF, Gutman R, Hanna L, Hillner BE, March A, Romanoff J, Siegel BA, Smith K, Song Y, Weber C, Whitmer RA, Gatsonis C.

JAMA Neurol. 2023 Nov 1;80(11):1166-1173. doi: 10.1001/jamaneurol.2023.3490.

A Remotely Coached Multimodal Lifestyle Intervention for Alzheimer's Disease Ameliorates Functional and Cognitive Outcomes

Roach JC, Rapozo MK, Hara J, Glusman G, Lovejoy J, Shankle WR, Hood L; COCOA Consortium:.

J Alzheimers Dis. 2023;96(2):591-607. doi: 10.3233/JAD-230403.

The several ways to authentically cure Alzheimer's dementia

Fessel J.

Ageing Res Rev. 2023 Dec;92:102093. doi: 10.1016/j.arr.2023.102093. Epub 2023 Oct 20.

Protocol of a Phase II Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial of S-Adenosyl Methionine in Participants with Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease

Holper S, Watson R, Churilov L, Yates P, Lim YY, Barnham KJ, Yassi N.

J Prev Alzheimers Dis. 2023;10(4):800-809. doi: 10.14283/jpad.2023.55.

Targeting memory loss with aspirin, a molecular mechanism perspective for future therapeutic approaches

Gholami M, Sadegh M, Koroush-Arami M, Norouzi S, Arismani RJ, Asadi E, Amini M, Khodayari N.

Inflammopharmacology. 2023 Dec;31(6):2827-2842. doi: 10.1007/s10787-023-01347-1. Epub 2023 Nov 4.

The effectiveness of dance movement interventions for older adults with mild cognitive impairment, Alzheimer's disease, and dementia: A systematic scoping review and meta-analysis

Tao D, Awan-Scully R, Ash GI, Pei Z, Gu Y, Gao Y, Cole A, Baker JS.

Ageing Res Rev. 2023 Dec;92:102120. doi: 10.1016/j.arr.2023.102120. Epub 2023 Nov 8.

Tackling seizures in patients with Alzheimer's disease

Tombini M, Boscarino M, Di Lazzaro V.

Expert Rev Neurother. 2023 Jul-Dec;23(12):1131-1145. doi: 10.1080/14737175.2023.2278487. Epub 2023 Dec 15.

Unlocking the therapeutic potential of natural stilbene: Exploring pterostilbene as a powerful ally against aging and cognitive decline

Dutta BJ, Rakshe PS, Maurya N, Chib S, Singh S.

Ageing Res Rev. 2023 Dec;92:102125. doi: 10.1016/j.arr.2023.102125. Epub 2023 Nov 17.

NeuroEPO plus (NeuralCIM(®)) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial

Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators.

Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w.

The Role of TNF-α in Alzheimer's Disease: A Narrative Review

Plantone D, Pardini M, Righi D, Manco C, Colombo BM, De Stefano N.

Cells. 2023 Dec 26;13(1):54. doi: 10.3390/cells13010054.

Chitosan hydrogel nanoparticle enhance therapeutic effect of bovine umbilical mesenchymal stem cell conditioned medium on canine cognitive dysfunction or canine Alzheimer's like mediated by inhibition of neuronal apoptotic

Wihadmadyatami H, Zulfikar MA, Herawati H, Pratama DAOA, Saragih GR, Kustiati U, Handayani AN.

Open Vet J. 2023 Dec;13(12):1504-1516. doi: 10.5455/OVJ.2023.v13.i12.1. Epub 2023 Dec 31.

Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets

Vakili O, Asili P, Babaei Z, Mirahmad M, Keshavarzmotamed A, Asemi Z, Mafi A.

CNS Neurol Disord Drug Targets. 2023;22(9):1335-1354. doi: 10.2174/1871527321666220829164211.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias